Corbus Pharmaceuticals Holdings, Inc.
- CRBP
- NASDAQ
- Biotechnology
- Oncology Therapeutics
- Antibody-Drug Conjugates (ADC)
- Obesity Drugs
$4.41
Today −2.43%Quote Oct 19, 2026, 02:04 PM UTC
−37.74%over the last month
Max drawdown −45.1%From 1-month high −42.6%3 months −49.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$85.3M
Quote Oct 19
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$33.67
+663.5% from here
Floor
$3.91
11.3% below price
Where the price sits
16 analysts
Analyst range, low to high
$33.00$35.00
- Price $4.41
- Resistance $4.52
- Consensus $33.67
The price is right under resistance. Analysts' average target sits about 663% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CRBPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
36